The Anti-Freaze-F Study- "Anti-TNF for Treatment of Frozen Shoulder

Status Completed

Clinical Trial Summary

Frozen shoulder is a common condition affecting approximately 9% of people aged 25-64 years. During the early phase the pain is usually unbearable and the later restriction in movement is severely limiting. It occurs when the flexible tissue (capsule) that surrounds the shoulder joint becomes inflamed, thickened and tight. The pain can be very severe and lasts 3-9 months, followed by a 4-12 month period of increasing stiffness, after which the condition usually improves. Frozen shoulder often affects a person's ability to sleep, carry out everyday activities, and work. Current treatments include rest, painkillers, anti-inflammatories, physiotherapy and steroid injections. If stiffness persists, surgery is sometimes recommended. However, there is no evidence that any of these treatments lead to significant benefit in the long term, with many being ineffective. The aim of this study is to find out if it is possible to run a larger trial to test whether an injection of adalimumab can reduce pain and prevent the disease from getting worse, if given during the early painful phase of frozen shoulder. The investigators need to conduct this smaller study first to be sure it's possible to identify and treat people with early stage frozen shoulder, before they conduct a much larger trial to find out if this treatment works. In this study the investigators will include 84 adults from 5 sites with painful early stage frozen shoulder who have not yet received treatment. People will be randomised to receive either an injection of the drug adalimumab or a dummy injection of saline (placebo) directly into the shoulder joint, both guided by ultrasound. All participants will also receive standardized advice on how to manage their shoulder pain. The investigators will assess participants before treatment and three months later. Adalimumab has been used very successfully to treat other inflammatory diseases such as rheumatoid arthritis. This study has been funded by the NIHR RfPB programme and 180 Life Sciences.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05299242
Study type	Interventional
Source	University of Oxford
Contact
Status	Completed
Phase	Phase 2/Phase 3
Start date	July 21, 2022
Completion date	June 12, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06181461` - Gong's Versus Kaltenborn Mobilization on Pain, Range of Motion and Function in Adhesive Capsulitis	N/A
Recruiting	`NCT03676829` - Embolization for the Treatment of Pain Secondary to Adhesive Capsulitis	Phase 1/Phase 2
Completed	`NCT05897866` - Sayed Issa's Hybrid Shoulder Arthroscopic-Open Surgical Management (HSSM)	N/A
Completed	`NCT04747938` - Frozen Shoulder Treated by Energy Accumulator	N/A
Recruiting	`NCT05979974` - High Energy Density Pulse Electromagnetic Field for Patients With Frozen Shoulder	N/A
Completed	`NCT02169206` - Clinical Trial on Frozen Shoulder Using Bilateral Shoulder Radiography in Different Position	N/A
Enrolling by invitation	`NCT03861923` - Dry Needling for Shoulder Adhesive Capsulitis	N/A
Not yet recruiting	`NCT05956171` - The Effects of Two Different Treatment Protocols on Shoulder Function, Quality of Life, and Ultrasound Parameters in Patients With Frozen Shoulder	N/A
Completed	`NCT03320200` - A Central Nervous System Focused Treatment Approach for Frozen Shoulder	N/A
Recruiting	`NCT04738253` - Correlation Between Ultrasonography Finding and Shoulder Range of Motion in Stroke Patients
Not yet recruiting	`NCT06129006` - Ultrasound Guided Shoulder Anterior Capsular Infiltration Plus Hydrodilatation With Steroid Versus Hyalase in Patients With Frozen Shoulder	N/A
Completed	`NCT02944526` - The Effect of 3 Ropivacaine Suprascapular Nerve Blocks in Subacute Adhesive Capsulitis: a Randomized Controlled Trial	Phase 4
Recruiting	`NCT02283996` - Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment	Phase 4
Completed	`NCT02006719` - Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder	Phase 2
Completed	`NCT01483963` - AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder	Phase 2
Completed	`NCT04369144` - Adding Vertical Correction to Scapular Recognition on Patients With Frozen Shoulder	N/A
Completed	`NCT03951896` - Efficacy of Platelet Rich Plasma Injections in Patients With Adhesive Capsulitis of the Shoulder	Early Phase 1
Completed	`NCT05993000` - Assessment of Frozen Shoulder Treatment Using 432 Hertz Frequency Music: A Clinical Trial	N/A
Completed	`NCT05372497` - Central Nervous System Focused Therapy in Frozen Shoulder	N/A
Completed	`NCT04044196` - Preoperative Psychological Risk Factors for the Retractable Capsulitis of the Shoulder After Shoulder Rotator Cuff Repair Surgery

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Anti-Freaze-F Study- "Anti-TNF for Treatment of Frozen Shoulder - a Feasibility Study" — Anti-FreazeF

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms